MORE THAN 50 MEDICINES IN DEVELOPMENT FOR COPD
Today, more than 13 million American adults suffer from COPD, one of
the most common lung diseases in the United States. COPD is a
progressive lower respiratory disease that encompasses two main
conditions – chronic bronchitis and emphysema. COPD is characterized
by obstructed airflow to the lungs that interferes with normal
breathing. People with COPD may be limited in their ability to work,
exercise and perform routine activities.
America€™s biopharmaceutical research companies are working on 54
medicines to treat COPD. According to a new report by the
Pharmaceutical Research and Manufacturers of America (PhRMA). These
exciting therapies are in late-stage development, meaning they are
either in clinical trials or awaiting review by the U.S. Food and
Drug Administration (FDA).
According to the National Institutes of Health (NIH), the number of
patients with COPD is increasing. In addition to those who have been
diagnosed with the disease, 12 million Americans likely have COPD
without knowing it. See More
Research study - Do you have COPD? Using computers and mobiles to help keep active.
Common household products should carry asthma warnings, research concludes.
Have a read at this???
